Kane Biotech Stock Today
| KNBIF Stock | USD 0.07 0 3.07% |
Performance0 of 100
| Odds Of DistressLess than 34
|
Kane Biotech is trading at 0.0727 as of the 19th of January 2025. This is a 3.07 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.0727. Kane Biotech has about a 34 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 19th of January 2025. Click here to learn more.
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada. The company has 124.83 M outstanding shares. More on Kane Biotech
Moving together with Kane OTC Stock
| 0.61 | NVO | Novo Nordisk AS Downward Rally | PairCorr |
| 0.83 | CSLLY | CSL | PairCorr |
| 0.74 | CMXHF | CSL Limited | PairCorr |
| 0.85 | REGN | Regeneron Pharmaceuticals | PairCorr |
Moving against Kane OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Kane OTC Stock Highlights
| President CEO | Mark AhrensTownsend |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Kane Biotech [KNBIF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kane Biotech's market, we take the total number of its shares issued and multiply it by Kane Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Kane Biotech classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 124.83 M outstanding shares.
Kane Biotech has accumulated about 2.53 M in cash with (2.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Check Kane Biotech Probability Of Bankruptcy
Ownership AllocationKane Biotech maintains a total of 124.83 Million outstanding shares. Kane Biotech holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Kane Ownership Details
Kane Biotech Risk Profiles
| Mean Deviation | 1.73 | |||
| Standard Deviation | 4.4 | |||
| Variance | 19.33 | |||
| Risk Adjusted Performance | (0.06) |
Kane Stock Against Markets
Picking the right benchmark for Kane Biotech otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Kane Biotech otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Kane Biotech is critical whether you are bullish or bearish towards Kane Biotech at a given time. Please also check how Kane Biotech's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Kane Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Kane Biotech Corporate Management
Elected by the shareholders, the Kane Biotech's board of directors comprises two types of representatives: Kane Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kane. The board's role is to monitor Kane Biotech's management team and ensure that shareholders' interests are well served. Kane Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kane Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kevin Cole | Pres Inc | Profile | |
| Wendy Nachtigall | Director Marketing | Profile | |
| Gregory Schultz | Chief Board | Profile | |
| Lorne Gorber | Investor Relations | Profile | |
| Ray Dupuis | Chief Officer | Profile |
Other Information on Investing in Kane OTC Stock
Kane Biotech financial ratios help investors to determine whether Kane OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kane with respect to the benefits of owning Kane Biotech security.